Skip to main content

Uterine Sarcoma Clinical Trials

Review the uterine sarcoma clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-8 of 8

Tailoring Therapy in Post-surgical Patients with Low-risk Endometrial Cancer
Status: Active
Location: 71 locations
Letrozole in Uterine Leiomyosarcoma
Status: Active
Location: 8 locations
Short Course Vaginal Cuff Brachytherapy in Treating Patients with Stage I-IIIA Endometrial Cancer
Status: Active
Location: 3 locations
Cytoreductive Surgery with Gemcitabine Followed by Dacarbazine for the Treatment of Locally Recurrent Uterine Leiomyosarcoma
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
An EHR-Based Comprehensive Bone and Soft Tissue Tumor Registry
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas